Real-World Patterns and Outcomes of Anticoagulation Therapy in Pulmonary Embolism: An Observational Dual-Centre Registry Analysis.

Although numerically higher mortality was recorded in the dabigatran subgroup and higher recurrence rates in the rivaroxaban and dabigatran subgroups, these findings did not reach statistical significance.

also in 111,027 other papers